Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future...

Area of Science:

• Cardiology
• Internal Medicine
• Pharmacology

Background:

• Heart Failure (HF) is a global health crisis with rising prevalence.
• Iron deficiency is a frequent comorbidity impacting HF patient outcomes.
• Cardiology societies worldwide endorse iron deficiency treatment in HF.

Purpose of the Study:

• To address the lack of practical recommendations for intravenous iron use in HF.
• To provide detailed guidance on administering intravenous iron to HF patients.
• To bridge the gap between clinical evidence and practical application of iron therapy in HF.

Main Methods:

• Review of current clinical guidelines and evidence regarding iron deficiency in HF.
• Analysis of the benefits of intravenous iron, specifically ferric carboxymaltose.
• Compilation of practical considerations for the administration of intravenous iron.

Main Results:

• Intravenous iron, particularly ferric carboxymaltose, demonstrates clinical benefits in HF patients.
• These benefits are observed irrespective of the patient's anemia status.
• Existing practical recommendations for iron use in HF are insufficient.

Conclusions:

• Intravenous iron administration is a valuable therapeutic option for HF patients with iron deficiency.
• Further practical guidance is essential to optimize the use of intravenous iron in clinical settings.
• Addressing iron deficiency is crucial for improving well-being and outcomes in heart failure management.